Researcher Profiles

Return to member profile

Grace L. Lu-Yao, PhD, MPH

Selected Publications

  1. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE.  An assessment of radical prostatectomy for prostate cancer: time trends, geographic variations, and outcomes. JAMA 1993; 260:2633-2636.
  2. Lu-Yao GL, Greenberg R. Geographic variation in rates of prostate cancer and radical prostatectomy in the United States. Lancet 1994; 343:251-54.
  3. Lu-Yao GL, Potosky A, Albertsen P, Wasson J, Wennberg JE.  Follow-up cancer treatments after radical prostatectomy among patients with prostate cancer. Journal of National Cancer Institute 1996; 88:166-173.
  4. Lu-Yao GL, Yao S.  Outcomes of treatments for clinically localized prostate cancer. Lancet 1997; 349:906-910.
  5. Yao S and Lu-Yao GL.  Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay. J Natl Cancer Inst 1999; 91:1950-6.
  6. Lu-Yao GL, Albertsen PC, Stanford JL, Stukel TA, Walker-Cornery ES, Barry MJ.  A natural experiment examining the impact of aggressive screening and treatment on prostate cancer mortality.  British Medical Journal 2002; 325:740-43.
  7. Lu-Yao G, Stukel TA, Yao SL.  Prostate-specific antigen screening in elderly men.  J Natl Cancer Inst 2003; 95:1792-7.
  8. Lu-Yao GL, Moore DF, Shih W, Lin Y, DiPaola RS, Albertsen P, SL Yao, Survival following primary androgen deprivation therapy among men with localized prostate cancer.  JAMA 2008; 300:173–181.
  9. Lu-Yao GL, Albertsen P, Moore DF, Barry M, Zietman A, O’Leary M, Walker-Corkery B, Shih W, Lin Y, DiPaola RS, Yao SL.  Outcomes of localized prostate cancer following conservative management.  JAMA 2009; 302(11):1202-1209.
  10. Lu-Yao GL, Albertsen P, Moore DF, Barry M, Zietman A, O’Leary M, Walker-Corkery B, Shih W, Lin Y, DiPaola RS, Yao SL.  Outcomes of localized prostate cancer following conservative management.  JAMA 2009; 302(11):1202-1209.
  11. Shao YU, Demissie K, Shih W, Mehta A, Stein M, Roberts C, DiPaola RS, Lu-Yao GL.  Contemporary profile of prostate cancer in the US. JNCI 2009;101:1280-1283.   
  12. Shao YU, PC Albertsen, Roberts CB, Lin Y, Mehta A, Stein M, Roberts C, DiPaola RS, Lu-Yao GL.  Risk profiles and treatment patterns among men with a prostate specific antigen level below 4.0 ng/ml at cancer diagnosis.  Archive of Internal Medicine 2010; 170(14):1256-1261. PMCID: PMC3651841.
  13. Lu-Yao GL, Albertsen PC, Li H, Moore DF, Shih W, Lin Y, DiPaola R, Yao SL. Does Primary Androgen Deprivation Therapy Delay the Receipt for Secondary Cancer Therapy for Localized Prostate Cancer? European Urology. 2012; 62(6):966-72. PMCID: PMC3472155.
  14. Lu-Yao GL, Albertsenn PC, Moore DF, Shih  WJ, Lin Y, DiPaola RS, Yao SL 15-Year Survival Outcomes Following Primary Androgen Deprivation Therapy for Localized Prostate Cancer. JAMA Intern Med. 2014 Jul 14. doi: 10.1001/jamainternmed.2014.3028. [Epub ahead of print]